Your browser doesn't support javascript.
loading
Changing patterns of invasive meningococcal disease and future immunization strategies.
Taha, Muhamed-Kheir; Bekkat-Berkani, Rafik; Abitbol, Véronique.
Afiliación
  • Taha MK; Institut Pasteur, Invasive Bacterial Infections Unit, National Reference Centre for Meningococci and Haemophilus Influenza, Paris, France.
  • Bekkat-Berkani R; GSK, Rockville, MD, USA.
  • Abitbol V; GSK, Rueil-Malmaison, France.
Hum Vaccin Immunother ; 19(1): 2186111, 2023 12 31.
Article en En | MEDLINE | ID: mdl-37017273
Invasive meningococcal diseases, which include meningitis, are rare and unpredictable, but may lead to very important/debilitating long-term sequelae, death, or reduced life expectancy. Vaccination is the best way to prevent them. Vaccination recommendations provided by national health agencies usually target infants (or toddlers), children, and adolescents. Older adults are only considered when they are at risk for invasive meningococcal diseases.Here, we analyzed the vaccination strategies for invasive meningococcal disease in different countries to identify the gaps preventing access to vaccination.We found that recommendations for invasive meningococcal disease vaccination vary markedly among countries. Vaccination programs target mainly infants and toddlers, and they successfully reduced the number of cases among them. However, we also observed that the disease now affects more adults. We also found that the lack of equitable access to vaccination prevents broader meningococcal protection for persons of any age.With this analysis, we suggest improving the current meningococcal vaccination guidelines to also provide adolescents and healthy older adults with access to vaccines. Promoting equal access to vaccination for everyone could reduce the impact on the healthcare system and help reduce social disparity. In order to do so, we advise universal recommendation of meningococcal vaccines, which would provide clear guidance to health-care practitioners.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas Meningococicas / Infecciones Meningocócicas / Neisseria meningitidis Tipo de estudio: Incidence_studies / Prognostic_studies Límite: Adolescent / Aged / Humans / Infant Idioma: En Revista: Hum Vaccin Immunother Año: 2023 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas Meningococicas / Infecciones Meningocócicas / Neisseria meningitidis Tipo de estudio: Incidence_studies / Prognostic_studies Límite: Adolescent / Aged / Humans / Infant Idioma: En Revista: Hum Vaccin Immunother Año: 2023 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Estados Unidos